Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 401.17M | 967.71M | 443.54M | -262.38M | 1.04B | 354.21M |
Gross Profit | -23.32M | 871.50M | 341.43M | -298.49M | 1.04B | 334.53M |
EBITDA | 291.44M | 424.71M | 102.54M | -335.24M | 835.30M | 293.87M |
Net Income | 171.87M | 258.15M | 83.61M | -326.08M | 732.99M | 211.72M |
Balance Sheet | ||||||
Total Assets | 5.83B | 6.79B | 5.13B | 5.65B | 6.56B | 4.07B |
Cash, Cash Equivalents and Short-Term Investments | 85.40M | 66.67M | 4.32B | 43.01M | 52.66M | 10.91M |
Total Debt | 641.00K | 16.70M | 1.88M | 3.30M | 253.00K | 992.00K |
Total Liabilities | 3.99B | 4.75B | 3.49B | 4.06B | 4.75B | 2.92B |
Stockholders Equity | 1.82B | 2.02B | 1.62B | 1.58B | 1.80B | 1.10B |
Cash Flow | ||||||
Free Cash Flow | 241.20M | 201.23M | 84.42M | 257.31M | 590.30M | 218.75M |
Operating Cash Flow | 241.20M | 201.23M | 84.42M | 257.31M | 590.30M | 218.75M |
Investing Cash Flow | -6.05M | -17.31M | 11.08M | -19.18M | -151.26M | -107.10M |
Financing Cash Flow | -205.72M | -155.00M | -104.22M | -250.38M | -398.22M | -118.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | 1.01B | 8.50 | 0.00% | 0.14% | 132.11% | 5511.22% | |
75 Outperform | 903.28M | 8.65 | 8.93% | 3.36% | 16.93% | 17.52% | |
74 Outperform | C$884.53M | 5.19 | 9.91% | ― | 14.62% | ― | |
69 Neutral | 1.64B | 10.58 | 11.37% | 2.90% | 96.56% | 158.06% | |
68 Neutral | 733.57M | 19.53 | 14.22% | 9.47% | -1.64% | -40.68% | |
61 Neutral | 975.34M | -14.64 | 0.00% | ― | 469.58% | -150.58% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
Senvest Capital Inc. reported a significant turnaround in financial performance for the second quarter ended June 30, 2025, with a net income of $226.3 million or $92.75 per share, compared to a net loss of $71.7 million or $29.02 per share in the same period of 2024. This substantial improvement highlights the company’s strong recovery and positive financial trajectory, which may bolster its market position and investor confidence.
Senvest Capital Inc. announced the results of its 2025 Annual Meeting of Shareholders, where six director nominees proposed by management were elected with overwhelming support. Additionally, PricewaterhouseCoopers LLP was reappointed as the company’s auditors, indicating continuity in financial oversight.